The Umass Memorial Medical Group Difference
UMass Memorial Medical Group is one of the largest and most experienced caregiver networks on the East Coast.
Our 1,100 medical group doctors see patients at more than 70 convenient locations in central Massachusetts. Our health care professionals are medical school faculty members, researchers and lifelong learners. Above all, they’re compassionate caregivers.
Let's Help You
Our Academic Medicine Tradition
All of our primary care doctors and specialists maintain faculty positions at the University of Massachusetts Medical School, our partner school. We constantly teach, learn and bring the latest health care discoveries and treatment options to those needing them most: Our patients.
Learn more about our research and teaching with UMass Medical School.
Our Medical Services and Specialties
If you’re a patient who needs a primary care physician or top-notch specialist, we’ve got the caregiver for you. If you’re a referring physician, your research is done. The specialist your patient needs is right here. Learn more about:
Dr. Finberg Talks About Future Flu Pandemic Prevention
More than 675,000 people died when the influenza pandemic hit the United States in 1918. Technology and science have advanced in the past 100 years, yet health officials still fear a new type of virus could cause another global pandemic. “What’s different about influenza is its ability to cause pandemics. Most viruses just can’t do that,” said Robert Finberg, MD, chair, Department of Medicine, in a recent Telegram & Gazette article. “Do I think it’s a worry? Yes, it’s a worry. Much more than Ebola, because we don’t know how to contain it.” Preparations to prevent and manage another flu pandemic are ongoing at science laboratories, government health agencies and health care organizations, including our Medical School and Medical Center.
Medical Group Physicians Participate in Mammography Study
Our Medical Center is participating alongside 100 mammography clinics across the United States and Canada in a clinical trial called TMIST (Tomosynthesis Mammographic Imaging Screening Trial) to determine if 3D mammography is better than 2D mammography for breast cancer screening. Unlike 2D screening, 3D screening uses tomosynthesis, which takes images from several different angles around the breast to generate the 3D image. Gopal Vijayaraghavan, MD, director of the division of breast imaging, said, “It’s hoped that based on mammography morphology, we’ll be able to identify tumors that are more aggressive and tailor treatment accordingly.”
A Calling for Cancer Care
UMass Memorial Health Care recently launched an Opioid Crisis Task Force with a primary mission of decreasing opioid-associated morbidity and mortality in Central Massachusetts communities. Announced at launch was the appointment of Kavita Babu, MD, as the system’s first chief opioid officer. The task force plans to catalog and share preventative efforts; identify and treat opioid use disorders through clinical and research endeavors; and establish priorities for initiatives that emphasize evidence-based care for patients with opioid use disorders.